Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Edwards Lifesciences Announces Groundbreaking Results from EARLY TAVR Trial for Asymptomatic Severe Aortic Stenosis.
Product Description
Edwards Lifesciences today unveiled results from the EARLY TAVR Trial, highlighting the advantages of early intervention with transcatheter aortic valve replacement (TAVR) for asymptomatic severe aortic stenosis patients.
Fundz sees it the moment Edwards Lifesciences ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tiago hidden
Pierre hidden
Amy hidden
Sannaa hidden
Product Launch Insights
What this usually meansEdwards Lifesciences shipped something new. Fundz reads product launches, trademark filings and hiring together.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.